一种水溶性疏水缔合聚合物二临界缔合行为研究

对三元共聚疏水缔合聚合物（丙烯酰胺／十八烷基二甲基烯丙基氯化铵／苯乙烯）的临界缔合浓度进行研究,发现其具有二临界缔合现象以及其在二临界缔合浓度附近不同的耐温抗盐的流变行为。研究结果表明,该疏水缔合聚合物的第一临界缔合浓度（C1^＊）为500mg／L,第二临界缔合浓度（C2^＊）为2400mg／L;C2^＊附近聚合物溶液的耐温性能较差;抗盐性能表现出三种不同的情况：随着盐质量浓度的增加,C〈C1^＊时,溶液粘度下降;C1^＊〈C〈C2^＊时,溶液粘度先增加后下降;C〉C2^＊时,溶液粘度先快速增加,后缓慢增加,最后下降。     

水溶性量子点的制备及其与壳聚糖衍生物的自组装

以3-巯基丙酸(HS-CH2CH2COOH)为稳定剂, 制备了水溶性的碲化镉(CdTe)量子点(QDs), 考察了制备条件对QDs荧光性能的影响及CdTe QDs与壳聚糖及叶酸和聚乙二醇改性的壳聚糖的自组装. 研究发现, 壳聚糖及改性壳聚糖与QDs的复合物荧光强度相对纯的CdTe QDs明显增强, 且QDs被包裹在内核, 复合粒子呈明显的核/壳结构. 改性壳聚糖/QDs复合物较小且尺寸分布更为均一.     

气液色谱有限浓度法研究醇类在芳烃溶剂中的自缔合及交叉缔合

气液色谱有限浓度法研究醇类在芳烃溶剂中的自缔合及交叉缔合王毅琳,周效贤,李松林,郑国康（兰州大学化学系,兰州,７３００００）关键词醇,自缔合,交叉缔合前文［１］用气液色谱有限浓度法研究了Ｃ４各正构醇在角鲨烷中的活度系数．本文报道在３１３．１５Ｋ下对Ｃ...     

两亲性壳聚糖衍生物的合成及其自聚集现象

以壳聚糖为主链, 聚乙二醇单甲醚为亲水性链段, 癸二酸为疏水链段, 合成了一系列两亲性壳聚糖衍生物. 通过FTIR, 1H NMR和X射线粉末衍射等手段对壳聚糖衍生物进行了结构表征, 由元素分析方法计算出衍生物的取代度. 采用直接溶解法制备了壳聚糖衍生物的空白胶束, 通过透射电子显微镜(TEM)观察了胶束的形态. 由动态光散射(DLS)测定了胶束的粒径及分布, 并以芘为分子探针, 通过荧光光谱法测定了壳聚糖衍生物的临界聚集浓度(CAC). 研究结果表明, 壳聚糖主链上疏水链段的取代度越大, 其衍生物的临界聚集浓度越低, 相同浓度下的胶束的粒径也越小.     

疏水缔合聚丙烯酰胺在盐水中的自组装行为

使用静态光散射、动态光散射以及原子力显微镜(AFM)研究了疏水缔合聚丙烯酰胺(HAPAM)在盐水溶液中的自组装行为.研究了聚合物分子在不同盐浓度中的表观重均分子量(Mw,a),均方根回转半径(),流体力学半径(),第二维里系数(A2)的变化,并根据/的比值得出聚合物分子的聚集形态.实验结果表明:随着盐浓度的增强,聚合物溶液的分子链由舒展变得卷曲.     

疏水性咪唑类混合离子液体的物理化学性质

本文选取疏水性和疏水性离子液体混合物作为研究对象, 将疏水性离子液体1-甲基-3-n-丁基咪唑三氟甲基磺酰胺盐[BMImN(CF3SO2)2]与BMImPF6以不同的比例进行混合, 对混合离子液体及其相应单组分离子液体进行了相关物理化学性质的测试和对比, 讨论由于混合导致的物理化学效应.     

阴离子疏水缔合共聚物/阳离子蠕虫状胶束协同增粘自组装网络

将阴离子疏水缔合丙烯酰胺共聚物P(NaAMC14S-b-AM)与阳离子蠕虫状胶束十六烷基三甲基溴化铵/水杨酸钠(CTAB/NaSal)在水溶液中自组装制备了新型的缔合增粘体. 由稳态剪切和动态流变实验结果得出: 自组装体系在80 ℃下仍具有显著的协同增粘效应, 其流变行为符合Maxwell模型. 同蠕虫状胶束相比, 自组装体系的稳态模量G0、力学松弛时间τR和缠结点密度ν都有增加, 由此分析缔合体系中两组分间形成了相互缠结的网络结构, 在链缠结处共聚物主链上的疏水侧链嵌入到了蠕虫状胶束的内核.     

两亲性香豆胶衍生物溶液中的缔合行为

以共价酯键方式将长链十二烷基与十六烷基引入羧甲基化香豆胶的大分子骨架上,制得了不同取代度的两亲性香豆胶衍生物(HmCmFG).采用稳态荧光法,通过探针芘的发射光谱与激发光谱研究了HmCmFG在NaCl溶液中的疏水缔合行为.结果表明:增加疏水烷基链长、提高烷基取代度或增大NaCl浓度均有利于疏水缔合作用的增强,使由芘激发谱中荧光响应值显著变化得出的临界缔合浓度降低.在一定HmCmFG浓度(cP)范围内,芘在疏水微区与水相中的浓度比值(cm/cw)与cnp成正比关系(n为幂指数),拟合计算的荧光响应曲线与实验结果相符合,得出芘的分配系数(KP)随疏水烷基取代度增加而增大.     

疏水亲脂作用驱动的有机分子的簇集和自卷

疏水亲脂相互作用(HLI)是一种重要的分子间弱作用力,本文主要介绍了HLI驱动下的有机分子分子的簇集和自卷的研究进展,作者实验室发展的一些新的概念、影响有机分子簇集和自卷的各种因素和运用这些概念对一些疾病产生原因的解释。     

荧光探针法研究疏水改性聚丙烯酰胺溶液的疏水缔合行为

采用胶束共聚 共水解方法合成疏水改性水溶性聚合物聚(丙烯酰胺/丙烯酸钠/N 辛基丙烯酰胺)[P(AM/NaAA/C8AM)],并以芘为荧光探针,应用稳态荧光光谱法研究了它的疏水缔合行为。结果表明,随聚合物浓度、疏水单体摩尔分数、疏水侧链长和温度的增加,疏水缔合作用增强;不同疏水单体含量的P(AM/NaAA/C8AM)的临界缔合浓度为1.5~3.0 g/L;表面活性剂十二烷基硫酸钠(SDS)与P(AM/NaAA/C8AM)发生了强烈的疏水相互作用,形成混合胶束,得到SDS的临界胶束浓度(CMC)为8×10-3 mol/L;由于聚合物链上羧基的存在,使其具有良好的 pH敏感性,随 pH值的增大,P(AM/NaAA/C8AM)的疏水缔合作用呈现先减弱后恒定再增强的变化。     

壳聚糖及其衍生物对重金属离子的吸附

壳聚糖的结构中含有大量的—NH₂和—OH,因此其对重金属离子有优良的吸附作用。但是作为天然高分子物质,壳聚糖的吸附性能又受到其自身物理形态、原料来源、脱乙酰度及体系pH值的影响,因此,对其进行物理和化学改性是提高壳聚糖吸附性能、扩大应用范围的必要手段。本文综述了壳聚糖的改性方法及其衍生物对重金属离子吸附作用的研究进展,并对其在重金属污染废水处理方面的前景作了展望。     

壳聚糖的结构特性及其衍生物的应用

壳聚糖由甲壳素经脱乙酰基而得,又称为可溶性甲壳素。壳聚糖的结构特征使其具有了独特的物理化学性质和生物活性。本文介绍了壳聚糖的结构特性、重要的化学性质及衍生物的应用。     

壳聚糖及其衍生物在组织工程中的应用

壳聚糖由于具有良好的生物相容性、生物可降解性以及具有可反应的活性基团,因而在生物、医学等领域具有广泛的研究和应用。随着组织工程学研究的深入,壳聚糖及其衍生物材料作为天然高分子组织工程支架越来越受到重视,综述了近年来国内外壳聚糖及其衍生物在组织工程上的研究和应用情况,包括壳聚糖及其衍生物支架材料的制备方法、壳聚糖的改性以及壳聚糖复合材料等。     

Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections

Antibiotics played an important role in controlling the development of enteric infection. However, the emergence of antibiotic resistance and gut dysbiosis led to a growing interest in the use of natural antimicrobial agents as alternatives for therapy and disinfection. Chitosan is a nontoxic natural antimicrobial polymer and is approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration). Chitosan and chitosan derivatives can kill microbes by neutralizing negative charges on the microbial surface. Besides, chemical modifications give chitosan derivatives better water solubility and antimicrobial property. This review gives an overview of the preparation of chitosan, its derivatives, and the conjugates with other polymers and nanoparticles with better antimicrobial properties, explains the direct and indirect mechanisms of action of chitosan, and summarizes current treatment for enteric infections as well as the role of chitosan and chitosan derivatives in the antimicrobial agents in enteric infections. Finally, we suggested future directions for further research to improve the treatment of enteric infections and to develop more useful chitosan derivatives and conjugates.     

壳聚糖及其衍生物在分析化学中的应用

介绍了壳聚糖及其衍生物在分离富集、色谱固定相、电化学分析和生物传感器等方面的应用研究进展,并展望了其在分析化学中的应用前景。     

Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives

Chitosan and its derivatives can alleviate metabolic syndrome by different regulation mechanisms, phosphorylation of AMPK (AMP-activated kinase) and Akt (also known as protein kinase B), suppression of PPAR-γ (peroxisome proliferator-activated receptor-γ) and SREBP-1c (sterol regulatory element–binding proteins), and translocation of GLUT4 (glucose transporter-4), and also the downregulation of fatty-acid-transport proteins, fatty-acid-binding proteins, fatty acid synthetase (FAS), acetyl-CoA carboxylase (acetyl coenzyme A carboxylase), and HMG-CoA reductase (hydroxy methylglutaryl coenzyme A reductase). The improved microbial profiles in the gastrointestinal tract were positively correlated with the improved glucose and lipid profiles in hosts with metabolic syndrome. Hence, this review will summarize the current literature illustrating positive correlations between the alleviated conditions in metabolic syndrome hosts and the normalized gut microbiota in hosts with metabolic syndrome after treatment with chitosan and its derivatives, implying that the possibility of chitosan and its derivatives to serve as therapeutic application will be consolidated. Chitosan has been shown to modulate cardiometabolic symptoms (e.g., lipid and glycemic levels, blood pressure) as well as gut microbiota. However, the literature that summarizes the relationship between such metabolic modulation of chitosan and prebiotic-like effects is limited. This review will discuss the connection among their structures, biological properties, and prebiotic effects for the treatment of metabolic syndrome. Our hope is that future researchers will consider the prebiotic effects as significant contributors to the mitigation of metabolic syndrome.     

Preparation and Antimicrobial Activity of Chitosan and Its Derivatives: A Concise Review

Despite the advantages presented by synthetic polymers such as strength and durability, the lack of biodegradability associated with the persistence in the environment for a long time turned the attention of researchers to natural polymers. Being biodegradable, biopolymers proved to be extremely beneficial to the environment. At present, they represent an important class of materials with applications in all economic sectors, but also in medicine. They find applications as absorbers, cosmetics, controlled drug delivery, tissue engineering, etc. Chitosan is one of the natural polymers which raised a strong interest for researchers due to some exceptional properties such as biodegradability, biocompatibility, nontoxicity, non-antigenicity, low-cost and numerous pharmacological properties as antimicrobial, antitumor, antioxidant, antidiabetic, immunoenhancing. In addition to this, the free amino and hydroxyl groups make it susceptible to a series of structural modulations, obtaining some derivatives with different biomedical applications. This review approaches the physico-chemical and pharmacological properties of chitosan and its derivatives, focusing on the antimicrobial potential including mechanism of action, factors that influence the antimicrobial activity and the activity against resistant strains, topics of great interest in the context of the concern raised by the available therapeutic options for infections, especially with resistant strains.     

壳聚糖及其衍生物应用于肥胖治疗的研究进展

肥胖是并发高血脂、脂肪肝、糖尿病和心脑血管损害等疾病的主要危险因子,减肥药物（食品）是一种有效的控制体重的手段。壳聚糖对脂肪和胆固醇具有良好的吸附性能,正在成为一种新型的减肥药物（食品）。结合本课题研究方向,综述了药用壳聚糖及其衍生物在治疗肥胖及其并发症方面应用的研究进展。通过在壳聚糖C6住-OH上改性制备了水溶性、油溶性和两亲性良好的壳聚糖衍生物,并通过动物试验研究了其减肥功效。     

壳聚糖衍生物的制备及其吸附性能

壳聚糖衍生物的制备及其吸附性能曲荣君，马千里，郑秀丽，孙言志（烟台师范学院化学系烟台２６４０２５）关键词壳聚精衍生物，制备，吸附壳聚糖（ＣＴＳ）是重金瞩离子的吸附剂￣［１，２］，由于壳聚精分子中的－ＮＨ＿２在ｐＨ较低的水溶液易形成而使ＣＴＳ溶于水，造...     

Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier

Chitosan is a non-toxic biological material, but chitosan is insoluble in water, which hinders the development and utilization of chitosan. Chitosan derivatives N-2-Hydroxypropyl trimethyl ammonium chloride (N-2-HACC) and carboxymethyl chitosan (CMCS) with good water solubility were synthesized by our laboratory. In this study, we synthesized mesoporous SiO₂ nanoparticles by the emulsion, and then the mesoporous SiO₂ nanoparticles were modified with γ-aminopropyltriethoxysilane to synthesize aminated mesoporous SiO₂ nanoparticles; CMCS and N-2-HACC was used to cross-link the aminated mesoporous SiO₂ nanoparticles to construct SiO₂@CMCS-N-2-HACC nanoparticles. Because the aminated mesoporous SiO₂ nanoparticles with positively charged can react with the mucous membranes, the virus enters the body mainly through mucous membranes, so Newcastle disease virus (NDV) was selected as the model drug to evaluate the performance of the SiO₂@CMCS-N-2-HACC nanoparticles. We prepared the SiO₂@CMCS-N-2-HACC nanoparticles loaded with inactivated NDV (NDV/SiO₂@CMCS-N-2-HACC). The SiO₂@CMCS-N-2-HACC nanoparticles as delivery carrier had high loading capacity, low cytotoxicity, good acid resistance and bile resistance and enteric solubility, and the structure of NDV protein encapsulated in the nano vaccine was not destroyed. In addition, the SiO₂@CMCS-N-2-HACC nanoparticles could sustain slowly released NDV. Therefore, the SiO₂@CMCS-N-2-HACC nanoparticles have the potential to be served as delivery vehicle for vaccine and/or drug.